Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Accumulated Expenses (2024 - 2025)

Historic Accumulated Expenses for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to $1.0 million.

  • RenovoRx's Accumulated Expenses fell 653.78% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 653.78%. This contributed to the annual value of $1.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that RenovoRx reported Accumulated Expenses of $1.0 million as of Q3 2025, which was down 653.78% from $885000.0 recorded in Q2 2025.
  • RenovoRx's Accumulated Expenses' 5-year high stood at $1.3 million during Q4 2024, with a 5-year trough of $737000.0 in Q1 2024.